Skip to the page

Data / Drug companies / Chlorthalidone

Chlorthalidone: 42 companies and 105 products in the FDA NDC directory

Chlorthalidone is listed in the FDA National Drug Code Directory by 42 companies, with 105 products in commercial distribution. 103 of the products (98.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on September 21, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
42
Products
105
Generic (ANDA) products
103 (98.1%)
Application numbers
20
Routes
Oral
Brand names
Hemiclor, Thalitone
openFDA record search
api.fda.gov

Companies that list chlorthalidone

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Bryant Ranch Prepack11tabletGeneric drugs (ANDA)October 23, 2024
A-S Medication Solutions6tabletGeneric drugs (ANDA)May 20, 2021
Bryant Ranch Prepack5tabletGeneric drugs (ANDA)August 5, 2022
Northwind Health Company, LLC5tabletGeneric drugs (ANDA)December 2, 2022
Aphena Pharma Solutions - Tennessee, LLC4tabletGeneric drugs (ANDA)October 20, 2022
Dr. Reddy's Laboratories Inc.4tabletGeneric drugs (ANDA)October 20, 2022
Preferred Pharmaceuticals Inc.4tabletGeneric drugs (ANDA)July 24, 2026
Rising Pharma Holdings, Inc.4tabletGeneric drugs (ANDA)October 23, 2024
Bryant Ranch Prepack3tabletGeneric drugs (ANDA)August 5, 2022
Direct_Rx3tabletGeneric drugs (ANDA)October 1, 2025
Remedyrepack Inc.3tabletGeneric drugs (ANDA)March 4, 2026
Ajanta Pharma USA Inc.2tabletGeneric drugs (ANDA)May 20, 2021
Alembic Pharmaceuticals Inc.2tabletGeneric drugs (ANDA)August 29, 2022
Alembic Pharmaceuticals Limited2tabletGeneric drugs (ANDA)August 29, 2022
Amneal Pharmaceuticals LLC2tabletGeneric drugs (ANDA)July 1, 2019
Ascend Laboratories, LLC2tabletGeneric drugs (ANDA)February 13, 2020
Chartwell RX, LLC2tabletGeneric drugs (ANDA)February 26, 2019
Coupler LLC2tabletGeneric drugs (ANDA)January 28, 2025
Ipca Laboratories Limited2tabletGeneric drugs (ANDA)September 21, 2026
Jubilant Cadista Pharmaceuticals Inc.2tabletGeneric drugs (ANDA)March 31, 2021
Lifestar Pharma LLC2tabletGeneric drugs (ANDA)August 5, 2022
Macleods Pharmaceuticals Limited2tabletGeneric drugs (ANDA)July 1, 2026
Major Pharmaceuticals2tabletGeneric drugs (ANDA)January 12, 2026
Mylan Pharmaceuticals Inc.2tabletGeneric drugs (ANDA)February 26, 1981
Nivagen Pharmaceuticals, Inc.2tabletGeneric drugs (ANDA)May 28, 2018
NorthStar Rx LLC2tabletGeneric drugs (ANDA)November 21, 2019
PD-Rx Pharmaceuticals, Inc.2tabletGeneric drugs (ANDA)October 27, 2023
Sun Pharmaceutical Industries, Inc.2tabletGeneric drugs (ANDA)February 12, 2016
Tagi Pharma, Inc.2tabletGeneric drugs (ANDA)August 5, 2022
Umedica Laboratories USA Inc.2tabletGeneric drugs (ANDA)February 15, 2026
Unichem Pharmaceuticals (USA), Inc.2tabletGeneric drugs (ANDA)August 6, 2019
Zydus Lifesciences Limited2tabletGeneric drugs (ANDA)May 15, 2019
Zydus Pharmaceuticals USA Inc.2tabletGeneric drugs (ANDA)May 15, 2019
American Health Packaging1tabletGeneric drugs (ANDA)August 10, 2017
AvPAK1tabletGeneric drugs (ANDA)November 12, 2019
Casper Pharma LLC1tabletNew drug applications (NDA)November 27, 2019
Ingenus Pharmaceuticals, LLC1tabletNew drug applications (NDA)March 17, 2025
Mylan Institutional Inc.1tabletGeneric drugs (ANDA)June 12, 1998
PD-Rx Pharmaceuticals, Inc.1tabletGeneric drugs (ANDA)February 26, 1981
Proficient Rx LP1tabletGeneric drugs (ANDA)February 13, 2020
Proficient Rx LP1tabletGeneric drugs (ANDA)May 28, 2018
Safecor Health, LLC1tabletGeneric drugs (ANDA)March 26, 2026

Dosage forms

Dosage formProductsShare
Tablet105100%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)10398.1%
New drug applications (NDA)21.9%

Pharmacologic classes

ClassProducts
Thiazide-like Diuretic105

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.